Diabetes Mellitus, Type 2

• Novo Nordisk Investigational Site — Alphen aan den Rijn, Netherlands
• Novo Nordisk Investigational Site — Crawley, United Kingdom

• Novo Nordisk Investigational Site — Bangalore, India

Not specified

• Novo Nordisk Investigational Site — Beijing, Beijing Municipality, China
• Novo Nordisk Investigational Site — Beijing, Beijing Municipality, China
• Novo Nordisk Investigational Site — Beijing, Beijing Municipality, China
• Novo Nordisk Investigational Site — Harbin, Heilongjiang, China

• Sanofi-Aventis Administrative Office — Tokyo, Japan

• Novo Nordisk Investigational Site — Bangalore, India

• GSK Investigational Site — Anniston, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Bull Shoals, Arizona, United States

• Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States
• sanofi-aventis Australia & New Zealand administrative office — Macquarie Park, Australia
• Sanofi-Aventis Administrative Office — Laval, Canada
• Sanofi-Aventis Administrative Office — Santiago, Chile

• Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States
• Sanofi-Aventis Administrative Office — Sofia, Bulgaria
• Sanofi-Aventis Administrative Office — Prague, Czechia
• Sanofi-Aventis Administrative Office — Cairo, Egypt

• Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States
• Sanofi-Aventis Administrative Office — São Paulo, Brazil
• Sanofi-Aventis Administrative Office — Santiago, Chile
• Sanofi-Aventis Administrative Office — Bogotá, Colombia